These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34600859)

  • 1. The epidemiology, pathophysiological mechanisms, and management toward COVID-19 patients with Type 2 diabetes: A systematic review.
    Yin Y; Rohli KE; Shen P; Lu H; Liu Y; Dou Q; Zhang L; Kong X; Yang S; Jia P
    Prim Care Diabetes; 2021 Dec; 15(6):899-909. PubMed ID: 34600859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature.
    Pedrosa AR; Martins DC; Rizzo M; Silva-Nunes J
    J Diabetes Complications; 2023 Feb; 37(2):108391. PubMed ID: 36621213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
    Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
    Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review.
    Lisco G; De Tullio A; Giagulli VA; Guastamacchia E; De Pergola G; Triggiani V
    Endocrine; 2020 Dec; 70(3):441-453. PubMed ID: 32779091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 in diabetic pregnancies: a systematic scoping review.
    Eberle C; James-Todd T; Stichling S
    BMC Pregnancy Childbirth; 2021 Aug; 21(1):573. PubMed ID: 34416856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes.
    Rajpal A; Rahimi L; Ismail-Beigi F
    J Diabetes; 2020 Dec; 12(12):895-908. PubMed ID: 32671936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes and severe COVID-19 infection: Connecting the dots.
    Bhattacharya S; Anne B; Tyagi P; Nagendra L; Kalra S
    J Pak Med Assoc; 2022 Nov; 72(11):2332-2334. PubMed ID: 37013318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and diabetes mellitus: a review of the incidence, pathophysiology and management of diabetes during the pandemic.
    Faruqi J; Balasubramanyam A
    Expert Rev Endocrinol Metab; 2023 Mar; 18(2):167-179. PubMed ID: 36797835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and Diabetes: An Epidemiologic Overview.
    Mannheim J; Johnson D
    Pediatr Ann; 2024 Jul; 53(7):e258-e263. PubMed ID: 38949874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Covid-19 and diabetes].
    Paquot N; Radermecker RP
    Rev Med Liege; 2020 Sup; 75(S1):138-145. PubMed ID: 33211437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of COVID-19 pathogenesis in diabetes.
    Aluganti Narasimhulu C; Singla DK
    Am J Physiol Heart Circ Physiol; 2022 Sep; 323(3):H403-H420. PubMed ID: 35776683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
    Jagat J M; Kalyan K G; Subir R
    Diabetes Metab Syndr; 2020; 14(5):829-831. PubMed ID: 32540737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 Diabetes Mellitus and COVID-19: A Narrative Review.
    Corrao S; Pinelli K; Vacca M; Raspanti M; Argano C
    Front Endocrinol (Lausanne); 2021; 12():609470. PubMed ID: 33868163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and ethnicity: A novel pathophysiological role for inflammation.
    Vepa A; Bae JP; Ahmed F; Pareek M; Khunti K
    Diabetes Metab Syndr; 2020; 14(5):1043-1051. PubMed ID: 32640416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of and From SARS-CoV-2 Infection and COVID-19 in People With Diabetes: A Systematic Review of Reviews.
    Hartmann-Boyce J; Rees K; Perring JC; Kerneis SA; Morris EM; Goyder C; Otunla AA; James OA; Syam NR; Seidu S; Khunti K
    Diabetes Care; 2021 Dec; 44(12):2790-2811. PubMed ID: 34711637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong.
    Lui DTW; Chung MSH; Lau EHY; Lau KTK; Au ICH; Lee CH; Woo YC; Wong CKH; Cowling BJ
    JAMA Netw Open; 2023 May; 6(5):e2314393. PubMed ID: 37204790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology.
    Suárez-Reyes A; Villegas-Valverde CA
    MEDICC Rev; 2021 Apr; 23(2):42. PubMed ID: 33974614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased circulating microparticles contribute to severe infection and adverse outcomes of COVID-19 in patients with diabetes.
    Sun H; Du Y; Kumar R; Buchkovich N; He P
    Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1176-H1193. PubMed ID: 36269646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.